Study of the oral hypoglycemic agent treatment after insulin therapy secession

Study of the oral hypoglycemic agent treatment after insulin therapy secession - Study of the oral hypoglycemic agent treatment after insulin therapy secession

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000009637

Enrollment

Registered

2012-12-26

Start date

2006-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

type 2 diabetes

Interventions

Mitiglinide gloup Voglibose gloup

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: HbA1c<6.5%(JDS) and total insulin units <16 U.

Exclusion criteria

Exclusion criteria: Patients falling under the [contraindication] in attached files of the experimental drugs. Patients whom principal investigator concludes to be unsuitable for the test, in other reasons.

Design outcomes

Primary

Measure	Time frame
HbA1c	—

Countries

Japan

Contacts

Public ContactWakana Miura

Tokai University School of Medicine Division of Nephrology, Endocrinology and Metabolism

happy0897@gmail.com0463-93-1121

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026